Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Moretti

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Anthracyclines: the first generation of cytotoxic targeted agents? A possible dreamAngelo Di Leo, Erica Moretti
Breast Cancer Research and Treatment|June 16, 2010
Re-searching anthracycline therapyCatherine Oakman, Erica Moretti, Angelo Di Leo
Experimental & Applied Acarology|December 12, 2022
Alternative food sources for Amblydromella caudiglans (Phytoseiidae) and effects on predationErica Moretti, Camden Jones, Rebecca Schmidt-Jeffris
Current Opinion in Oncology|August 29, 2009
Predicting anthracycline benefit: have we made any progress?Erica Moretti, Catherine Oakman, Angelo Di Leo
Future Oncology (London, England)|February 25, 2011
Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancerCatherine Oakman, Erica Moretti, Libero Santarpia, et al.
Cancer Treatment Reviews|September 18, 2009
The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patientsCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Triple negative breast cancer: a heterogeneous subgroup defined by what it is notCatherine Oakman, Erica Moretti, Giulia Pacini, et al.
Journal of the National Cancer Institute|November 7, 2009
Re: Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapyCatherine Oakman, Erica Moretti, Christos Sotiriou, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant systemic treatment for individual patients with triple negative breast cancerCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Anthracyclines: the first generation of cytotoxic targeted agents? A possible dreamAngelo Di Leo, Erica Moretti
Breast Cancer Research and Treatment|June 16, 2010
Re-searching anthracycline therapyCatherine Oakman, Erica Moretti, Angelo Di Leo
Experimental & Applied Acarology|December 12, 2022
Alternative food sources for Amblydromella caudiglans (Phytoseiidae) and effects on predationErica Moretti, Camden Jones, Rebecca Schmidt-Jeffris
Current Opinion in Oncology|August 29, 2009
Predicting anthracycline benefit: have we made any progress?Erica Moretti, Catherine Oakman, Angelo Di Leo
Future Oncology (London, England)|February 25, 2011
Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancerCatherine Oakman, Erica Moretti, Libero Santarpia, et al.
Cancer Treatment Reviews|September 18, 2009
The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patientsCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Triple negative breast cancer: a heterogeneous subgroup defined by what it is notCatherine Oakman, Erica Moretti, Giulia Pacini, et al.
Journal of the National Cancer Institute|November 7, 2009
Re: Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapyCatherine Oakman, Erica Moretti, Christos Sotiriou, et al.
Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant systemic treatment for individual patients with triple negative breast cancerCatherine Oakman, Erica Moretti, Francesca Galardi, et al.
Pageof 4